Quanterix-Lucent & Emocog enter exclusive Korea distribution agreement for Simoa platform for blood-based Alzheimer’s diagnostics: Seoul, Republic of Korea Thursday, December 11 ...
New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...
No. 19 / 2025Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and ...
The industry’s mRNA alliance is demanding steady FDA leadership, warning that the current “unprecedented turmoil” at the ...
The flow cytometry market is expanding due to increased investment in immuno-oncology and liquid biopsy sectors. With advancements in genome-based research and single-cell analysis, flow cytometry ...
President Trump is shifting from discussion of the long-lasting competition among the world’s biggest economies and nuclear ...
Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing at a CAGR of 6.4% during 2025–2035.
Zacks Investment Research on MSN
BASFY launches low-VOC catalyst to align with sustainability goals
BASF SE BASFY announced the introduction of a modern amine catalyst, Lupragen N 208, to its line of Lupragen amine catalysts used for the production of polyurethane (PU) foams. This newest addition ...
Mangaluru stands as a premier institution of higher learning, distinguished by a 146-year Jesuit legacy that blends academic ...
This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback